NCT02894944View on ClinicalTrials.gov

Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

April 30, 2019

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

Theragene®,Ad5-yCD/mutTKSR39rep-ADP

Theragene®,Ad5-yCD/mutTKSR39rep-ADP is Adenovirus-mediated Double Suicide Gene Therapy

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
collaborator

NewGenPharm Inc.

UNKNOWN

lead

Seoul National University Hospital

OTHER

NCT02894944 - Clinical Trial Phase I for Theragene in Combination With Chemotherapy for the Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter